+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antivirals"

Cold Sore Treatment - Global Strategic Business Report - Product Thumbnail Image

Cold Sore Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 469 Pages
  • Global
From
Bee Propolis Extracts - Global Strategic Business Report - Product Thumbnail Image

Bee Propolis Extracts - Global Strategic Business Report

  • Report
  • June 2025
  • 371 Pages
  • Global
From
From
From
From
Herpes Zoster Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Zoster Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Herpes Labialis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Labialis Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Chronic Hepatitis B Virus Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Chronic Hepatitis B Virus Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Hepatitis D Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hepatitis D Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Marburg Virus Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Marburg Virus Disease Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Herpes Simplex Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Simplex Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Seasonal Influenza Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Seasonal Influenza Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Lassa Fever - Pipeline Insight, 2025 - Product Thumbnail Image

Lassa Fever - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
H1N1 Infection - Pipeline Insight, 2025 - Product Thumbnail Image

H1N1 Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Dengue- Pipeline Insight, 2025 - Product Thumbnail Image

Dengue- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Monkeypox - Competitive Landscape, 2024 - Product Thumbnail Image

Monkeypox - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Ebola Virus - Competitive Landscape, 2024 - Product Thumbnail Image

Ebola Virus - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
From
Loading Indicator

The Antivirals market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat viral infections. Antivirals are used to treat a wide range of viral infections, including influenza, HIV, herpes, hepatitis, and other respiratory infections. Antivirals work by targeting the virus itself, preventing it from replicating and spreading throughout the body. They can also be used to reduce the severity of symptoms and shorten the duration of the illness. Antivirals are typically administered orally or intravenously, depending on the type of virus and the severity of the infection. In some cases, antivirals may be used in combination with other drugs to increase their effectiveness. Some of the major companies in the Antivirals market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, and Bristol-Myers Squibb. These companies produce a variety of antiviral drugs, including those used to treat influenza, HIV, herpes, and hepatitis. Show Less Read more